课题基金 / 基金详情

The Aging Heart: A Roadmap to Cardiac Independence

The Aging Heart: A Roadmap to Cardiac Independence
衰老的心脏:心脏独立的路线图
批准号:
7805207
负责人:
Roger J. Hajjar
金额:
$2.0万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-09-30 至 2010-08-31

项目摘要

项目成果

Roger J. Hajjar的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请者提供):会议将促进在老龄化和心血管疾病领域的知名研究人员和早期职业科学家之间的知识共享,目的是阐明年龄和心脏病之间的联系,并为发现和开发疾病预防和管理的治疗方法提供基础。参加会议的行业代表将允许基础科学家和行业演讲者之间的互动,强调衰老生物学研究在心血管疾病中的翻译应用。 公共卫生相关性:本次会议的目标是评估目前对衰老和心血管疾病基本机制的了解,并确定这些领域的新诊断和治疗进展,以改善老年人的健康和福祉。
英文摘要
DESCRIPTION (provided by applicant): The conference will promote sharing of knowledge between established investigators and early-career scientists in the fields of aging and cardiovascular disease for the purpose of elucidating the links between age and heart disease and providing a foundation for discovery and development of therapeutic approaches to disease prevention and management. Industry representation in the conference will allow for interaction between basic scientists and industry speakers that will highlight the translational applications of research on the biology of aging in cardiovascular diseases. PUBLIC HEALTH RELEVANCE: The goals of this conference are to assess current knowledge of fundamental mechanisms of aging and cardiovascular disease and to identify novel diagnostic and therapeutic advances in these areas, so as to improve the health and well- being of the elderly.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Small Molecule Therapy for the Treatment of Heart Failure
  • 批准号:
    9335758
  • 项目类别:
  • 资助金额:
    $55.06万
  • 财政年份:
    2017
  • 负责人:
    Roger J. Hajjar
  • 依托单位:
Anti-AAV Antibodies as an Obstacle to Cardiac AAV Gene Therapy
Anti-AAV Antibodies as an Obstacle to Cardiac AAV Gene Therapy
Role of miR25 in Heart Failure
海外基金